1. Introduction {#sec1}
===============

Radiation at high doses is known to cause cytotoxic effects *in vitro* and *in vivo*; however, radiation at low doses induces an adaptive effect or hormesis, showing a protective effect on subsequent challenges-induced damage *in vitro* and *in vivo* \[[@B1], [@B2]\]. One of the major mechanisms for low-dose radiation (LDR) to induce adaptive response is the induction of cellular protective components that offer the protection against the damage induced by subsequent challenges including radiation, chemicals, and even diseases \[[@B3]\].

Diabetes mellitus (DM) is a global health problem due to its serious complications. Among diabetic complications, nephropathy probably is one of the major complications to increase the mortality of diabetic patients or impact their life quality. Although mechanisms by which diabetes induces the development of nephropathy are multiple, excessive production of reactive oxygen species (ROS) diabetic condition seems the primary factor \[[@B4]--[@B6]\]. We have phenomenally observed the protective effect of LDR on various diabetic complications, including the testicular, renal, and cardiac damages in diabetic rats and mice \[[@B7]--[@B10]\]. In fact, an early study from other groups also implicated the protective effect of LDR on brain damage in the diabetic rat model \[[@B11]\]. In order to explore the protective mechanisms by which LDR prevents diabetic complications, we have proposed LDR may stimulate cell survival and growth signaling pathways and up-regulate antioxidant system.

Among cell survival pathways, the protein kinase B (PKB)/Akt, as a family of serine/threonine protein kinases, plays important roles in a diverse numbers of processes including cell survival, cell growth, gene expression, apoptosis, protein synthesis, energy metabolism, and oncogenesis. Several publications have demonstrated the protective role of Akt in preventing the pathogenesis of diabetic nephropathy \[[@B12]\].

Nuclear factor E2--related factor-2 (Nrf2) is a key transcription factor in regulating intracellular redox balance and a sensor of oxidative and electrophilic stress. Nrf2 regulates intracellular antioxidants, phase II detoxifying enzymes, and many other proteins that detoxify xenobiotics and neutralize ROS and/or RNS to maintain cellular redox homeostasis. NAD(P)H quinone oxidoreductase (NQO1), heme oxygenase-1 (HO-1), and glutathione S-transferase are among the well-studied Nrf2 target genes that are upregulated through the antioxidant response element regulatory element in response to oxidative stress \[[@B13]--[@B15]\]. The important role of Nrf2 in combating oxidative stress induced by diabetes has been demonstrated by the increased cardiac and renal sensitivity of Nrf2^−/−^ mice to diabetes \[[@B13], [@B16], [@B17]\].

The present study, therefore, was to test our hypotheses that LDR protection from diabetes-induced renal damage may include the stimulation of cell survival pathways and the upregulation of antioxidant system. To this end, we have used a type 1 diabetic model that was induced by streptozotocin (STZ) as used before \[[@B7]--[@B10]\]. We irradiated these diabetic mice and age-matched controls to different forms of LDR, and then immediately investigate whether LDR can stimulate Akt as a key cell survival pathway and Nrf2 expression and transcription function as the most important antioxidative mechanism. We found that single 25 mGy of X-rays did not, but single 75 mGy or accumulated 75 mGy (25 mGy daily × 3) of X-rays could significantly stimulate Akt function. These two forms of LDRs also significantly upregulate Nrf2 expression and transcription. The latter was reflected by stimulation of Nrf2 downstream antioxidants including NQO1 and HO-1. Therefore, stimulation of these cell survival pathway and antioxidative mechanisms may play the critical role in the prevention of diabetic renal damage and dysfunction by LDR.

2. Materials and Methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

Eight weeks old male C57BL/6J mice were purchased from and also housed in Jilin University Animal Center at 22°C with a 12 : 12-light-dark cycle and free access to rodent chow and tap water for ≥2 weeks before being used for experiments. All animal procedures were approved by the University Animal Care and Use Committee, which is certified by the Chinese Association of Accreditation of Laboratory Animal Care. Body weights of mice were measured every 3 days.

2.2. Induction of Type 1 Diabetes {#sec2.2}
---------------------------------

Mice were randomly divided into two groups, a STZ-treated diabetic group and age-matched control group. STZ (Sigma Chemical, St. Louis, MO) was freshly dissolved in 0.05 M sodium citrate buffer (pH 4.5). Both groups of mice were fasted overnight and then were given by intraperitoneal injection of STZ at 60 mg/kg body weight daily for 6 consecutive days or equivalent volume of the citrate buffer. Blood glucose level was determined using a Freestyle glucometer 1 week after the last injection of STZ. We considered mice to be diabetic when blood glucose was ≥12 mmol/L.

2.3. Whole-Body LDR {#sec2.3}
-------------------

A Phillips therapeutic X-ray machine (XSS 205FZ) was operated at 200 kV and 10 mA in the presence of 1.0 mm Al and 0.5 mm Cu filters. LDR was given to mice in whole body at dose of 25 mGy or 75 mGy with a dose rate of 12.5 mGy/min.

Mice from both diabetic and age-matched control groups were randomly divided into two groups with and without LDR that is, total four groups: control, LDR, DM, and DM/LDR. For LDR groups, mice were further divided into 3 groups: a single dose of 25 mGy, a single dose of 75 mGy, and accumulated 75 mGy (25 mGy daily for 3 days). Eight mice from each group were euthanized at 1, 3, 6, 9, and 12 h after LDR exposure. The protocol was approved by the Committee on the Ethics of Animal Experiments of Jilin University, Jilin, China (Permit Number: 2007-0011). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.

2.4. Western Blotting {#sec2.4}
---------------------

Tissue lysates were prepared in lysis buffer (1% Triton X-100, 150 mmol/L NaCl, 50 mmol/L Tris, pH 8.0, 1 mmol/L EDTA, 10 mg/L phenylmethylsulfonyl fluoride) using a homogenizer on ice. Then supernatants were collected after centrifugation at 12,000 rpm at 4°C for 10 min. Protein concentration was determined by the Bradford assay. Equal amount (50 *μ*g protein/lane) of proteins and prestained molecular weight marker (Gibco-BRL, Gaithersburg, MD) were loaded onto 12% SDS-polyacrylamide gels in a minigel apparatus (Mini-Protean II; Bio-Rad). After being separated on an SDS-PAGE gel, proteins were transferred to PVDF membranes (0.45 *μ*m pore size; Millipore). Nonspecific binding to the membrane was blocked for 1 h at room temperature with 5% nonfat milk in TBST buffer (20 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween-20). Membranes were then incubated at 4°C with primary antibody in blocking buffer containing 5% nonfat milk shaking overnight. Primary antibodies used in the present study include antimouse Nrf2 antibody (1 : 500, Abcam, Cambridge, MA), antimouse NQO1 antibody (1 : 500, Abcam), antimouse Akt antibody antimouse p-Akt antibody, and antimouse Akt2 antibody (1 : 1000, Cell Signaling Technology, Danvers, MA), and HO-1 antibody (1 : 100, Santa Cruz, CA). After washing with TBST three times, membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 1 h (CST 1 : 2000). The same membrane was probed with *β*-actin (1 : 1000) as loading control. Blots were developed with enhanced chemiluminescent reagent and target band density was scanned using a Molecular Dynamics 300A Laser Densitometer.

2.5. Immunohistochemical Staining {#sec2.5}
---------------------------------

Sections were blocked with Superblock buffer (Pierce, Rockford, IL) for 30 min. Sections then were incubated with primary antibodies of anti-Akt, anti-phorspho-Akt, anti-Akt2, and anti-Nrf2, as used for Western blotting assays in 1 : 50 dilution overnight at 4°C. Following washing with PBS for 3 times, these sections were incubated with biotin-labeled secondary antibody at room temperature for 1 h, followed by color development with diaminobenzidine for 2 min.

2.6. Statistical Analysis {#sec2.6}
-------------------------

Data were collected from repeated experiments and were presented as means ± SD (*n* = 8). Comparisons were performed by one-way ANOVA for the different groups, followed by a post *hoc* Tukey\'s test for the difference between groups using statistical software SPSS 14.0. Differences were considered to be significant at *P* ≤ 0.05.

3. Results {#sec3}
==========

3.1. Diabetic Animal Model and LDR Effects {#sec3.1}
------------------------------------------

Whole-blood glucose levels were similar among experimental groups before induction of diabetes by STZ. One week after the last dose of STZ, whole-blood glucose levels were examined. Once hyperglycemia was diagnosed, diabetic mice and age-matched control mice were exposed or shamed to LDR either at single 25 mGy, single 75 mGy, or accumulated 75 mGy (e.g.: 25 mGy daily for 3 days). Body weights among groups were same before study. STZ-induced diabetes prevented the body-weight gain that occurred in age-matched control group ([Figure 1(a)](#fig1){ref-type="fig"}). No effect of LDR on the body-weight gain no matter exposure levels ([Figure 1(a)](#fig1){ref-type="fig"}). [Figure 1(b)](#fig1){ref-type="fig"} shows that whole-blood glucose levels in the DM group significantly increased and LDR did not affect whole-blood glucose levels either in control or diabetic mice.

3.2. LDR Increased Renal Akt Function under Diabetic Conditions {#sec3.2}
---------------------------------------------------------------

Immunohistochemical staining revealed that the phosphorylated Akt, predominantly localized in the glomerulus of the kidney, was significantly increased at 1, 3 and 6 h after diabetic mice were exposed to 75 mGy of X-rays ([Figure 2(a)](#fig2){ref-type="fig"}).

Western blot showed that there was no significant difference for the expression level of renal Akt phosphorylation at Ser 473 (*p*-Akt) between Control and DM groups. Exposure of control mice to 75 mGy did not significantly increase renal *p*-Akt level at the times 1--12 h after irradiation compared to control mice (Figures [2(b)](#fig2){ref-type="fig"}, [2(c)](#fig2){ref-type="fig"}).

Compared to control, exposure of diabetic mice to a single 25 mGy LDR did not affect renal *p*-Akt levels; however, exposure to LDR at either a single 75 mGy or an accumulated 75 mGy (25 mGy × 3) significantly increased renal *p*-Akt levels from 1--12 h with a peak at 6 h for 75 mGy and from 1--6 h with a peak at 6 h for accumulated 75 mGy (Figures [2(b)](#fig2){ref-type="fig"}, [2(c)](#fig2){ref-type="fig"}).

3.3. LDR Increased Renal Akt2 Expression under Diabetic Conditions {#sec3.3}
------------------------------------------------------------------

Immunohistochemical staining revealed that the expression of Akt2, predominantly localized in the glomerulus of the kidney, was significantly increased in DM/LDR group at 3 and 6 h after irradiation with 75 mGy of X-rays ([Figure 3(a)](#fig3){ref-type="fig"}).

Compared to control, exposure of control mice to 75 mGy did not significantly change renal Akt2 expression at any postirradiation time-point. Renal Akt2 expression was significantly decreased in DM group compared with Control, detected by immunohistochemical staining and western blot (Figures [3(a)](#fig3){ref-type="fig"}--[3(d)](#fig3){ref-type="fig"}).

Compared to diabetic mice, exposure of diabetic mice to a single 25 mGy LDR also did not affect renal Akt2 expression level ([Figure 3(b)](#fig3){ref-type="fig"}); however, exposure to either a single 75 mGy (Figures [3(b)](#fig3){ref-type="fig"}, [3(d)](#fig3){ref-type="fig"} or an accumulated 75 mGy (25 mGy × 3, Figures [3(c)](#fig3){ref-type="fig"}, [3(d)](#fig3){ref-type="fig"} significantly increased renal Akt2 levels from 3--9 h with a peak at 6--9 h for the single 75 mGy and from 3--6 h with a peak at 6 h for the accumulated 75 mGy, respectively ([Figure 3(d)](#fig3){ref-type="fig"}).

3.4. LDR Partially Prevented Diabetic Downregulation of Renal Nrf2 Expression {#sec3.4}
-----------------------------------------------------------------------------

Immunohistochemical staining revealed that Nrf2 expression, predominantly localized in the glomerulus ([Figure 4(a)](#fig4){ref-type="fig"}). The intensity of Nrf2 staining was significantly lower in the kidney of diabetic mice than control or diabetic mice treated with LDR at post 6 h ([Figure 4(a)](#fig4){ref-type="fig"}).

Western blotting showed that the accumulation of Nrf2 was significantly lower in the kidney of diabetic mice than that of corresponding control mice (Figures [4(b)](#fig4){ref-type="fig"}, [4(c)](#fig4){ref-type="fig"}). Exposures of diabetic mice to LDR at single 25 mGy did not have any impact on diabetic inhibition of Nrf2 expression; however, exposure to the single 75 mGy significantly prevented diabetic inhibition of the expression of renal Nrf2 in a time-dependent manner from 1 to 6 h after irradiation (Figures [4(b)](#fig4){ref-type="fig"}, [4(c)](#fig4){ref-type="fig"}). Exposure of diabetic mice to the accumulated 75 mGy (25 mGy × 3) also significantly prevented the inhibition of renal Nrf2 expression in diabetic kidney at 3 and 6 h after LDR (Figures [4(b)](#fig4){ref-type="fig"}, [4(c)](#fig4){ref-type="fig"}).

3.5. LDR Partially Prevented Diabetic Downregulation of Renal Nrf2 Function {#sec3.5}
---------------------------------------------------------------------------

Since Nrf2 is a transcription factor to positively regulate the expression of several downstream genes to play important role in the prevention of oxidative stress and damage, we have examined several of its downstream genes to functionally evaluate Nrf2 in the kidney of diabetic mice with and without LDR. Renal NQO1 expression was found to significantly decrease in diabetic group compared with control, detected by western blot (Figures [5(a)](#fig5){ref-type="fig"}, [5(b)](#fig5){ref-type="fig"}). Exposure of diabetic mice to 25 mGy LDR did not have any effect on renal NQO1 protein expression. However, exposure of diabetic mice to either single 75 mGy or accumulated 75 mGy X-rays significantly prevented diabetic inhibition of renal NQO1 protein expression at 3 and 6 h after LDR (Figures [5(a)](#fig5){ref-type="fig"}, [5(b)](#fig5){ref-type="fig"}).

Renal HO-1 expression, examined by western blot, significantly decreased in DM groups compare to corresponding groups ([Figure 6](#fig6){ref-type="fig"}). Exposure of diabetic mice to single 25 mGy X-rays did not have any impact on its expression. In contrast, single 75 mGy or accumulated 75 mGy X-rays can significantly prevent diabetic inhibition of HO-1 expression at 3--9 h after irradiation ([Figure 6](#fig6){ref-type="fig"}).

4. Discussion {#sec4}
=============

In the present study, we have explored for the first time the effect of LDR on renal expression of Akt as cell survival pathway and Nrf2 as antioxidant transcription regulator in normal and diabetic conditions. We provided the following new findings: 75 mGy of X-rays can stimulate Akt signaling pathway and upregulate Nrf2 expression and function in diabetic kidneys; single exposure of 25 mGy did not, but three repeated 25 mGy of X-rays could offer similar effects as single 75 mGy exposure on the stimulation of Akt phosphorylation and the upregulation of Nrf2 expression and function.

In our recent study we have demonstrated that multiple exposures of STZ-induced diabetic mice to 25 mGy of X-rays significantly prevented diabetes-induced renal oxidative damage, inflammation, and fibrosis as well as renal dysfunction \[[@B9]\]. This prompted us to know whether there is a stimulation of either cell survival signaling or antioxidant pathway under diabetic condition by exposure to LDR. In the literature, several studies have used *in vitro* models to show that LDR was able to stimulate cell survival signaling such as Akt phosphorylation \[[@B18], [@B19]\]. However, whether LDR can stimulate Akt phosphorylation in the tissue of LDR-irradiated animals remain elusive, particularly under diabetic conditions. We found here that single or accumulated 75 mGy of X-rays can significantly stimulate the increase of renal Akt phosphorylation at 1--12 h with a peak at 6 h. We have reported that in the kidney of type 1 diabetic mice induced by STZ as used here, Akt plays an important role in preventing diabetes-induced renal cell death \[[@B20]\]. Similar antiapoptotic effect of Akt on the tissue or *in vitro* cultured cells in response to various pathogenic stimuli were also extensively reported \[[@B21]--[@B24]\]. Therefore, we assumed that the stimulation of Akt phosphorylation by LDR in the kidney of diabetic mice may be one of the possible mechanisms by which LDR prevents the development of diabetic nephropathy \[[@B9]\].

In our previous study, we have demonstrated that diabetes induced a significant increase of renal oxidative damage that was accompanied with renal inflammation and fibrosis, leading to renal dysfunction \[[@B9]\]. We also reported that LDR protection of rat testes from diabetes-induced cell death and oxidative damage was along with an upregulation of testicular superoxide dismutase levels \[[@B10]\]. These two pieces of important information stimulates us to ask whether LDR protect the kidney also through upregulation of antioxidants. Since Nrf2 plays a critical regulation of cellular antioxidant function and LDR was able to upregulate Nrf2 expression in cultured cell line \[[@B25]\], we investigated whether diabetes affects renal Nrf2 expression and whether LDR upregulates Nrf2 expression and function to increase the expression of antioxidants under diabetic conditions. Here we found that diabetes significantly down-regulate renal Nrf2 expression ([Figure 4](#fig4){ref-type="fig"}) and function (Figures [5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), which is consistent with other studies indicating the downregulation of Nrf2 under different pathogenic conditions, including diabetes \[[@B26]\].

We further found that exposure of diabetic mice to either single or accumulated 75 mGy of X-rays can significantly upregulate Nrf2 expression at 3--6 h after irradiation. The upregulated Nrf2 function by single or accumulated 75 mGy of X-rays was also reflected by the upregulation of its downstream antioxidants, including NQO1 at 3--6 h and HO-1 at 3--9 h (Figures [5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}). The difference of peak expression times and durations of these down-stream antioxidants suggests the slight difference of Nrf2 in regulating these antioxidant components at transcriptional level. Activation of Nrf2 by sulforaphane *in vitro* and by sulforaphane or MG132 *in vivo* has been reported to suppress high-level glucose-induced oxidative stress and metabolic dysfunction in human microvascular endothelial cells \[[@B27]\] and reduced diabetic proteinuria in STZ-induced diabetic rats \[[@B28], [@B29]\]. In addition, a recent study demonstrated that Nrf2 can bind to Bcl-2 gene antioxidant response element to upregulate antiapoptotic protein Bcl-2, leading to a prevention of apoptotic cell death \[[@B30]\]. Therefore, upregulation of Nrf2 expression and transcription function may not only turn on antioxidant mechanisms by increasing the expression of antioxidants, but also upregulate antiapoptotic pathways to reduce diabetes-induced renal cell death.

In terms of the hormesis, the optimal and effective doses were extensively documented as 75 mGy \[[@B7], [@B31]--[@B34]\]. Here we also showed a significantly stimulating effect of 75 mGy X-rays on the stimulation of Akt phosphorylation and the upregulation of Nrf2 expression and function. However, accumulated 75 mGy that was given by 3 daily exposures at 25 mGy was similarly effective as single 75 mGy on the stimulation of Akt phosphorylation, but single 25 mGy of X-rays did not have such effect. Our finding is consistent with a recent study that showed that repeated 20 mGy computed tomography scans did not induce genomic instability in reticulocytes, but conferred a significant resistance to larger doses of radiation-induced genomic instability in the bone marrow cells of irradiated mice while exposures to single computed tomography scans exhibit transient genotoxicity, enhanced apoptosis, and enhanced radiation sensitization to subsequent large dose of radiation \[[@B35]\]. This explains why in our previous studies repeated exposure to 25 mGy for 8--12 weeks could significantly prevent diabetes-induced renal and cardiac damage \[[@B9]\]. This is also consistent with the finding by Normura et al., that is, continuous low-dose-rate gamma irradiation ameliorates diabetic nephropathy and increases life span in db/db mice through the activation of renal antioxidants \[[@B36]\].

In summary, we have demonstrated that single or accumulated 75 mGy of X-rays can stimulate Akt signaling pathway and upregulate Nrf2 expression and function in diabetic kidneys. Considering that multiple exposure of diabetic mice to 25 mGy X-rays significantly prevented the development of diabetic nephropathy, we assumed here that the stimulated Akt phosphorylation and upregulated Nrf2 expression and function by LDR in the kidney of diabetic mice may be the mechanisms, in part at least, for the prevention by LDR of diabetic nephropathy.

The authors declare that they have no conflict of interests with SPSS 14.0 software, financial foundation, or any other third party.

This study was supported in part by a Basic Research Award from American Diabetes Association (1-11-BA-17, to L. Cai), a Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College (to L. Cai, X. Li and Y. Tan), and Young Scientist Award from National Science Foundation of China (81000294, to C. Zhang).

![Effects of LDR on the body weight and blood glucose in diabetic mice. Diabetic and age-matched control mice were irradiated in whole body with LDR (25 mGy, 3 × 25 mGy, or 75 mGy). Body weights (a) and fasting blood glucose levels (b) were measured before and after diabetes as well as before and after LDR at indicated time points (*n* = 8). Data was presented as mean ± SD. \**P* \< 0.05  *versus* Control. Pre-STZ: before diabetes induction by STZ; Pre-LDR: before diabetic and age-matched control mice were irradiated with LDR.](OXIMED2012-291087.001){#fig1}

![Effects of LDR on renal Akt function in diabetic mice. Renal tissues from mice exposed to sham, single 25 mGy, 75 mGy or 3 × 25 mGy of X-rays were collected at 1, 3, 6, 9, and 12 h after LDR to localize the phosphorylated Akt (*p*-Akt) at Ser473 with immunohistochemical staining ((a), the representative images of the staining were from the group of 75 mGy of LDR). The expression levels of total Akt and *p*-Akt were also examined by western blotting (b), followed by quantitative analysis (c). Data was presented as mean ± SD. ^\#^*P* \< 0.05  *versus* DM. Definition of the abbreviations is provided in [Figure 1](#fig1){ref-type="fig"} legend.](OXIMED2012-291087.002){#fig2}

![Effects of LDR on renal Akt2 expression in diabetic mice. Animals were treated and renal tissues were collected as described in [Figure 2](#fig2){ref-type="fig"}. The localization of Akt2 expression in the kidney was examined by immunochemical staining (a) and the expression of Akt2 and total Akt were detected by western blotting (b) followed by quantitative analysis (c). Data was presented as mean ± SD.   \**P* \< 0.05  *versus*Control, ^\#^*P* \< 0.05  *versus* DM.](OXIMED2012-291087.003){#fig3}

![Effects of LDR on renal Nrf2 expression in diabetic mice. Animals were treated and renal tissues were collected as described in [Figure 2](#fig2){ref-type="fig"}. The localization of Nrf2 expression in the kidney was examined by immunochemical staining (a) and the expression of Nrf2 were detected by western blotting (b) followed with quantitative analysis (c). Data was presented as mean ± SD.  \**P* \< 0.05 *versus*Control; ^\#^*P* \< 0.05  *versus* DM.](OXIMED2012-291087.004){#fig4}

![Effects of LDR on renal NQO1 expression in diabetic mice. Animals were treated and renal tissues were collected as described in [Figure 2](#fig2){ref-type="fig"}, respectively. The expression of NQO1 was detected by western blotting (b) followed with quantitative analysis (c).  \**P* \< 0.05  *versus* Control, ^\#^*P* \< 0.05  *versus* DM.](OXIMED2012-291087.005){#fig5}

![Effects of LDR on renal HO-1 expression in diabetic mice. Animals were treated and renal tissues were collected as described in [Figure 2](#fig2){ref-type="fig"}, respectively. The expression of HO-1 was detected by western blotting (b) followed with quantitative analysis (c). Data was presented as mean ± SD.  \**P* \< 0.05  *versus*Control, ^\#^*P* \< 0.05  *versus* DM.](OXIMED2012-291087.006){#fig6}
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